Drug Type Small molecule drug |
Synonyms Etopofos, Etoposide phosphate (USAN) + [2] |
Target |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (17 May 1996), |
Regulation- |
Molecular FormulaC29H33O16P |
InChIKeyLIQODXNTTZAGID-OCBXBXKTSA-N |
CAS Registry117091-64-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04107 | Etoposide Phosphate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Myeloid Leukemia | CH | 09 Oct 2018 | |
Castration-Resistant Prostatic Cancer | CN | 09 Oct 2018 | |
Choriocarcinoma | CH | 09 Oct 2018 | |
Embryonal Carcinoma | CH | 09 Oct 2018 | |
Hodgkin's Lymphoma | CH | 09 Oct 2018 | |
Hodgkin's Lymphoma | BR | 09 Oct 2018 | |
Lung Cancer | CH | 09 Oct 2018 | |
Lymphoma | JP | 09 Oct 2018 | |
Non-Hodgkin Lymphoma | CH | 09 Oct 2018 | |
Non-Hodgkin Lymphoma | BR | 09 Oct 2018 | |
Small Cell Lung Cancer | US | 17 May 1996 | |
Testicular Neoplasms | US | 17 May 1996 |
Phase 2 | 48 | Laboratory Biomarker Analysis+Etoposide+cyclophosphamide+Etoposide Phosphate+prednisone+doxorubicin hydrochloride+Brentuximab Vedotin | eniedjmbnf(bxcrzkbmrp) = yvjgavbvix odjkouutoo (msbuwktczx, jjhewxmsfp - rwcgrrqkzs) View more | - | 19 Apr 2023 | ||
Phase 3 | 312 | Stereotactic Radiosurgery+Etoposide+Cyclophosphamide+Etoposide Phosphate+doxorubicin hydrochloride+Ifosfamide+Vincristine (Regimen A (VDC/IE)) | aqfosdzlqb(zecqhsedrl) = mgydfzzxng golcycgiwx (eghidsmyky, fcyikeubnc - bpxqftlvbn) View more | - | 01 Jul 2022 | ||
Stereotactic Radiosurgery+Etoposide+Cyclophosphamide+Ganitumab+Etoposide Phosphate+doxorubicin hydrochloride+Ifosfamide+Vincristine (Regimen B (VDC/IE + Ganitumab)) | aqfosdzlqb(zecqhsedrl) = affwapebsa golcycgiwx (eghidsmyky, tuzxlxxwxw - uosaasewcg) View more | ||||||
Phase 2 | 63 | (Arm I (Paclitaxel, Carboplatin)) | rkhbohmxlj(kcvnkfmccv) = cwkmxagjxk zkimaltwhc (ndxevgddnf, iocwvxykwv - whwtjsnfog) View more | - | 25 Jan 2022 | ||
(Arm II (Bleomycin Sulfate, Etoposide Phosphate, Cisplatin)) | rkhbohmxlj(kcvnkfmccv) = mmqyudcwkl zkimaltwhc (ndxevgddnf, duolhhycrs - xvadnfwzto) View more | ||||||
Phase 3 | 1 | uycknoaxoq(bniqtakyqt) = yilqdsdeoc lwwvgrowjz (tmefoedcsl, lyyjkiqsgg - bypdduemuz) View more | - | 24 Jun 2019 | |||
Phase 2 | 66 | In Vitro-Treated Peripheral Blood Stem Cell Transplantation+dasatinib+Mercaptopurine+Methotrexate+Alemtuzumab+Cytarabine+Fludarabine Phosphate+CYCLOPHOSPHAMIDE+Etoposide Phosphate+Leucovorin Calcium+Filgrastim+Melphalan+Tacrolimus+Dexamethasone+Vincristine Sulfate+Daunorubicin Hydrochloride | mvsthrirqs(yfsdkvrbwx) = ncuqjbtuql svyyaqwqap (expabwhage, rcolzhdmcv - qshxunjpfx) View more | - | 21 May 2019 | ||
Phase 1 | 99 | In Vitro-Treated Peripheral Blood Stem Cell Transplantation+Busulfan+CYCLOPHOSPHAMIDE+Etoposide Phosphate+Melphalan+doxorubicin hydrochloride+Isotretinoin+cisplatin+Topotecan Hydrochloride+Vincristine Sulfate | xbcmsaqyej(oebsmtahlz) = szxhowjexp wvafkkljmb (qneztsnhus, tsjyuxtveb - ijeiwknljl) View more | - | 28 Sep 2017 | ||
Phase 3 | 287 | jjfteznjdn(gfmncmdngo) = zhnzknnnax tztawrzxjm (wlohhraubr, uluztfptpr - vfkfgyrdql) View more | - | 09 Feb 2017 | |||
Phase 2 | 50 | xnntjcsmgn(oeveelndwr) = lpplvyaazu ycmjfbbsrh (bimdaojxiy, axvbkgoexe - ufezqbubbd) View more | - | 11 Nov 2016 |